FDAnews
www.fdanews.com/articles/73809-fda-clears-analogic-s-lifegard-ii-patient-monitors

FDA CLEARS ANALOGIC'S LIFEGARD II PATIENT MONITORS

June 28, 2005

The FDA gave market clearance to Analogic for its LIFEGARD II family of noninvasive patient monitors.

The first LIFEGARD II release consists of five models. The basic units measure five parameters, while other models also monitor continuous noninvasive cardiac output and end-tidal CO2. Units come equipped with integrated printers for recording waveform and parameter values.

The first models of LIFEGARD II are scheduled to be released this summer and additional models with cleared capabilities are to be made available over the next 18 months. LIFEGARD II is the platform upon which the company will expand its patient monitoring offerings.